Fri, August 4, 2023

Andrea Tan Maintained (ABCL) at Strong Buy with Decreased Target to $24 on, Aug 4th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-24-on-aug-4th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrea Tan of Goldman Sachs, Maintained "AbCellera Biologics Inc." (ABCL) at Strong Buy with Decreased Target from $27 to $24 on, Aug 4th, 2023.

Andrea has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Andrea's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrea


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $28 on, Friday, May 5th, 2023

Publication Contributing Sources